# FDA Inspection 646606 - Baptist Health Lexington - February 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/baptist-health-lexington/232c3821-f13e-4b7e-ba07-19b2f665285f
Source feed: FDA_Inspections

> FDA Inspection 646606 for Baptist Health Lexington on February 17, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 646606
- Company Name: Baptist Health Lexington
- Inspection Date: 2010-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 965022 - 2016-04-07](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington/119f1da4-41aa-42cb-857c-88c953554dfa)
- [FDA Inspection 876369 - 2014-04-29](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington/7e43d83a-d046-4da7-bda8-54edc3a5773a)
- [FDA Inspection 771344 - 2012-03-08](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington/d6dc90c5-e0a7-4147-928b-63a969759bcd)

Company: https://www.keypedia.com/companies/baptist-health-lexington/2311d292-c113-4910-b25e-3e4248d20daf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d